Helping decide between nasal surgery options for chronic hypertrophic rhinitis

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This prospective randomized study enrolls about 158 adults with chronic hypertrophic rhinitis who are candidates for inferior turbinate surgery. Participants are assigned to standard shared decision-making or standard SDM plus a printed patient decision aid to compare pros and cons of surgical options. Outcomes include decision certainty (SURE scale), decision regret (DRS), and surgical satisfaction assessed before surgery and one month after. Blinded outcome assessors collect data to minimize bias. No invasive procedures are performed as part of the trial beyond the planned surgery, and the intervention focuses on decision support.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Diagnosed with chronic hypertrophic rhinitis.
* Outpatients or inpatients scheduled to undergo surgical intervention.
* Aged 18 years or older and able to communicate in Chinese.

Exclusion Criteria:

* Presence of other structural nasal pathologies (e.g., nasal polyps, tumors).
* Patients undergoing emergency surgery.
* Individuals unable to live independently or fully comprehend the questionnaire content.
* Individuals unable to complete the questionnaires.

Where it's running

• Shuang Ho Hospital
  New Taipei City, Taiwan Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Mannan-Conjugated Allergoids for House Dust M mite Allergy

  A new treatment named EP-088_MM09 is being tested to see if it can reduce nasal and eye allergy symptoms (and possibly asthma) in people aged 12 to 65 who are allergic to house dust mites, compared with a placebo.

  Recruiting at 2 sites Phase 3 Inmunotek S.L. · Covilha, Castelo Branco District and 15 other locations · NCT07904195

• Mannan-conjugated Allergoids for House Dust Mite Allergy

  A new treatment called EP-088_MM09 is being tested to see if it can reduce allergy symptoms in people with house dust mite–related nasal allergy, with or without mild asthma.

  Recruiting at 4 sites Phase 3 Inmunotek S.L. · Coimbra and 15 other locations · NCT07904052

• Dog-allergy immunotherapy with Alutard SQ Dog in Swedish practice

  This study tests whether Alutard SQ Dog immunotherapy helps adults with moderate-to-severe dog allergy when used in real-world Swedish care.

  Recruiting at 2 sites Phase 4 Karolinska Institutet · Lund, Skåne County and 1 other locations · NCT07651891

• PL-14 Allergy Blocker vs saline spray for seasonal nasal allergies

  This study tests whether PL-14 Allergy Blocker, a drug-free nasal gel, reduces nasal allergy symptoms in adults with seasonal allergic rhinitis compared with saline spray.

  Recruiting at 4 sites Polyrizon Ltd. · Normal, Illinois and 4 other locations · NCT07588672

• Digital app to improve adherence to aeroallergen immunotherapy

  This project will test whether a smartphone app can help people with allergic rhinitis keep taking their prescribed aeroallergen immunotherapy for the full treatment course.

  Recruiting Fundación de Investigación Biomédica - Hospital Universitario de La Princesa · Madrid, Madrid · NCT07419230

• Using a severity questionnaire for allergic rhinitis during ENT visits

  This project will try a short severity questionnaire during ENT follow-ups for adults with allergic rhinitis to see if patients find it acceptable and if the scores reliably reflect symptom severity.

  Recruiting University Hospital, Strasbourg, France · Strasbourg · NCT07315945

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.